drugset / Trial / NCT02956785
What After the First Propess
Phase 2
Terminated
85 enrolled
South Warwickshire NHS Foundation Trust
Medicem International · collabWalsall Healthcare NHS Trust · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to compare three different regimens for continuation of induction of labor after no spontaneous or artificial rupture of membranes could be achieved after first 24 hours post-insertion of Dinoprostone
Timeline
- Start
- 2017-01
- Primary completion
- 2022-11
- Completion
- 2022-11
Outcome
Outcome not reported
Stopped (Enrollment): “Inability to recruit more women because of the COVID-19 and staffing/resources issues”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dinoprostone | Other / unclassified | 3 mg | Other |
| Comparator | Dinoprostone | Other / unclassified | 10 mg | Other |
Indications
No indication recorded.